144 related articles for article (PubMed ID: 14872339)
1. Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma.
Nozoe T; Kohnoe S; Ezaki T; Kabashima A; Maehara Y
J Cancer Res Clin Oncol; 2004 Jun; 130(6):334-8. PubMed ID: 14872339
[TBL] [Abstract][Full Text] [Related]
2. The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma.
Liu WK; Chu YL; Zhang F; Chen P; Cheng F; Wang H; Jia YY; Ma TY
Arch Virol; 2005 May; 150(5):991-1001. PubMed ID: 15645378
[TBL] [Abstract][Full Text] [Related]
3. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
4. The relationship between cyclooxygenase-2, CD44v6, and nm23H1 in esophageal squamous cell carcinoma.
Liu WK; Fu Q; Li YM; Jiang XY; Zhang MP; Zhang ZX
Onkologie; 2009 Oct; 32(10):574-8. PubMed ID: 19816074
[TBL] [Abstract][Full Text] [Related]
5. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
8. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
[TBL] [Abstract][Full Text] [Related]
9. Relationship between intracellular localization of p34cdc2 protein and differentiation of esophageal squamous cell carcinoma.
Nozoe T; Takahashi I; Baba H; Maehara Y
J Cancer Res Clin Oncol; 2005 Mar; 131(3):179-83. PubMed ID: 15662526
[TBL] [Abstract][Full Text] [Related]
10. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Clin Cancer Res; 2007 Jul; 13(14):4046-50. PubMed ID: 17634528
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
13. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
15. Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma.
Hara T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2019 Mar; 26(3):899-906. PubMed ID: 30610559
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
17. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
Wang L; Liu Q; Lin D; Lai M
Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma.
Kausar T; Sharma R; Hasan MR; Tripathi SC; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
Cancer Invest; 2011 Jan; 29(1):42-8. PubMed ID: 20874003
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
20. Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.
Sakai M; Sohda M; Miyazaki T; Suzuki S; Sano A; Tanaka N; Inose T; Nakajima M; Kato H; Kuwano H
Anticancer Res; 2010 Mar; 30(3):851-6. PubMed ID: 20393006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
